Evidence map›Paper›PMID 16407838›Full record

ArticleOncogene2006

Fhit modulation of the Akt-survivin pathway in lung cancer cells: Fhit-tyrosine 114 (Y114) is essential.

S Semba, F Trapasso, M Fabbri, K A McCorkell, S Volinia, T Druck, D Iliopoulos, Y Pekarsky, H Ishii, P N Garrison and 3 more

RetractedErratum issuedOpen access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 71 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Identification of Fhit as a post-transcriptional effector of Thymidine Kinase 1 expression.Biochimica et biophysica acta. Gene regulatory mechanisms · 2017
    Article
  10. Article
  11. Role of Akt signaling in resistance to DNA-targeted therapy.World journal of clinical oncology · 2016
    Review
  12. Article
  13. Article
  14. Article
  15. Transcriptional regulation of the survivin gene.Molecular biology reports · 2014
    Review
  16. Article
  17. Article
  18. Article
  19. Src family kinases and paclitaxel sensitivity.Cancer biology & therapy · 2011
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

S SembaComprehensive Cancer Center and Department of Molecular Virology, Immunology, and Medical Genetics, The Ohio State University, Columbus, 43210, USA.
F Trapasso
M Fabbri
K A McCorkell
S Volinia
T Druck
D Iliopoulos
Y Pekarsky
H Ishii
P N Garrison
L D Barnes
C M Croce
K Huebner
The Ohio State University · USThe University of Texas Health Science Center at San Antonio · USJichi Medical University · JPUniversity of Ferrara · IT

Funding

TRAINING IN HEMATOPOIETIC &VASCULAR CELL FUNCTIONST32HL007780 · NHLBI · THOMAS JEFFERSON UNIVERSITY · PI CALABRETTA, BRUNO · 1994 to 2003
$369k
NHLBI NIH HHS T32-HL07780Telethon GTF03012
6 · The paper itself

Abstract

The Fhit tumor suppressor binds and hydrolyses diadenosine polyphosphates and the Fhit-substrate complex has been proposed as a proapoptotic effector, as determined by infection of susceptible cancer cells with adenoviruses carrying wild-type fragile histidine triad (FHIT) or catalytic site mutants. The highly conserved Fhit tyrosine 114 (Y114), within the unstructured loop C-terminal of the catalytic site, can be phosphorylated by Src family tyrosine kinases, although endogenous phospho-Fhit is rarely detected. To explore the importance of Y114 and identify Fhit-mediated signaling events, wild-type and Y114 mutant FHIT-expressing adenoviruses were introduced into two human lung cancer cell lines. Caspase-dependent apoptosis was effectively induced only by wild-type but not Y114 mutant Fhit proteins. By expression profiling of FHIT versus mutant FHIT-infected cells, we found that survivin, an Inhibitor of Apoptosis Protein (IAP) family member, was significantly decreased by wild-type Fhit. In addition, Fhit inhibited activity of Akt, a key effector in the phosphatidylinositol 3-OH kinase (PI3K) pathway; loss of endogenous Fhit expression caused increased Akt activity in vitro and in vivo, and overexpression of constitutively active Akt inhibited Fhit-induced apoptosis. The results indicate that the Fhit Y114 residue plays a critical role in Fhit-induced apoptosis, occurring through inactivation of the PI3K-Akt-survivin signal pathway.

Indexed as

Acid Anhydride HydrolasesAdenoviridaeBis(5'-adenosyl)triphosphataseBlotting, WesternClass I Phosphatidylinositol 3-KinasesFlow CytometryGene Expression ProfilingGene Expression RegulationGenes, Tumor SuppressorHumansInhibitor of Apoptosis ProteinsLung NeoplasmsMicrotubule-Associated ProteinsNeoplasm ProteinsOligonucleotide Array Sequence AnalysisPhosphatidylinositol 3-KinasesAcid Anhydride HydrolasesBIRC5 protein, humanBis(5'-adenosyl)triphosphataseClass I Phosphatidylinositol 3-KinasesInhibitor of Apoptosis ProteinsMicrotubule-Associated ProteinsNeoplasm ProteinsPhosphatidylinositol 3-KinasesPIK3CA protein, humanProto-Oncogene Proteins c-aktRNA, Small InterferingSurvivinTyrosine

Identifiers

PMID16407838
OpenAlexW2014225194

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.